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Abstract
Background: Postoperative delirium can result in increased postoperative morbidity and mortality, major demand
for postoperative care and higher hospital costs. Hypnotics serve to induce and maintain anaesthesia and to
abolish patients’ consciousness. Their persisting clinical action can delay postoperative cognitive recovery and
favour postoperative delirium. Some evidence suggests that these unwanted effects vary according to each
hypnotic’s specific pharmacodynamic and pharmacokinetic characteristics and its interaction with the individual
patient.
We designed this study to evaluate postoperative delirium rate after general anaesthesia with various hypnotics in
patients undergoing surgical procedures other than cardiac or brain surgery. We also aimed to test whether
delayed postoperative cognitive recovery increases the risk of postoperative delirium.
Methods/Design: After local ethics committee approval, enrolled patients will be randomly assigned to one of
three treatment groups. In all patients anaesthesia will be induced with propofol and fentanyl, and maintained
with the anaesthetics desflurane, or sevoflurane, or propofol and the analgesic opioid fentanyl.
The onset of postoperative delirium will be monitored with the Nursing Delirium Scale every three hours up to
72 hours post anaesthesia. Cognitive function will be evaluated with two cognitive test batteries (the Short
Memory Orientation Memory Concentration Test and the Rancho Los Amigos Scale) preoperatively, at baseline,
and postoperatively at 20, 40 and 60 min after extubation.
Statistical analysis will investigate differences in the hypnotics used to maintain anaesthesia and the odds ratios for
postoperative delirium, the relation of early postoperative cognitive recovery and postoperative delirium rate. A
subgroup analysis will be used to categorize patients according to demographic variables relevant to the risk of
postoperative delirium (age, sex, body weight) and to the preoperative score index for delirium.
Discussion: The results of this comparative anaesthesiological trial should whether each the three hypnotics tested
is related to a significantly different postoperative delirium rate. This information could ultimately allow us to select
the most appropriate hypnotic to maintain anaesthesia for specific subgroups of patients and especially for those
at high risk of postoperative delirium.
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Background
Postoperative delirium (PD), defined as altered percep-
tion with hallucinations, acute decline in cognition and
attention and inappropriate behaviour, is a severe and
relatively common clinical problem. It develops in up to
56% of the patients (higher risk in elderly patients and
after orthopaedic surgery) and is related to an increase in
hospital morbidity neuro-functional decline, nursing time
per patient, per-day hospital costs, length of hospital stay,
rates of nursing home placement and mortality rates
[1,2]. Drugs used to induce and maintain anaesthesia can
delay postoperative cognitive recovery and favour post-
operative delirium. These unwanted effects vary accord-
ing to each drug’s specific pharmacodynamic and
pharmacokinetic features and its interactions with the
individual patients’ characteristics [3,4]. The Interna-
tional Study of Postoperative Cognitive Dysfunction 1
(ISPOCD1), showed that general anaesthesia is related to
a postoperative cognitive dysfunction at 1 week in 25.8%
and 3 months postoperatively in 9.9% of the patients [5].
The ISPOCD 2 study reported, in 438 elderly patients, no
significant differences in POCD between general anaes-
thesia and local anaesthesia at 3 months follow up (14.3%
and 13.9%; p = 0.93) [6]. More recent studies suggest that
POCD and PD are more common after general anaesthe-
sia [7]. POCD at 3 months postoperatively also has major
long-term consequences including a higher risk of leav-
ing the labour market and dependency on social transfer
payments, but also leads to increased mortality at a med-
ian 8.5 years [8]. None of these studies have investigated
the possible effects on PD of the various anaesthetic/hyp-
notic regimens used to maintain anaesthesia.
This multicentre, double-blind, prospective, randomized,
controlled clinical trial is designed to evaluate PD rate
after general anaesthesia maintained with various hypno-
tics (desflurane, sevoflurane or propofol) in non-premedi-
cated adult patients undergoing surgical procedures other
than cardiac or brain surgery. We also aim to test whether
delayed postoperative cognitive recovery is related to an
increased risk of PD.
Postoperative Delirium and Post anaesthesia Cognitive
Recovery Study: PINOCCHIO Trial
Registered at Trial.gov Number: NCT00507195, July
24, 2007
The drugs to be tested in this trial are among the
most common anaesthetic hypnotics currently used for
maintaining anaesthesia.
Propofol
Propofol is an intravenous sedative-hypnotic agent used
to induce and maintain anaesthesia widely used in neu-
roanesthesia [9-13]. Propofol infusion induces a dose-
dependent vasodilation with arterial hypotension,
steady-state propofol blood concentrations are generally
proportional to infusion rates [3,9-11]. Propofol reduces
cerebral brain flow and cerebral O2 metabolism to a
similar extent, favourable pharmacokinetics and high-
quality recovery profile despite prolonged infusion
[12,13].
Sevoflurane
Sevoflurane has several properties which make it highly
useful as a day case anaesthetic. After propofol-induced
anaesthesia, awakening is faster from sevoflurane than
from isoflurane, faster than after propofol and comparable
(in most studies) to desflurane. Subsequent recovery and
discharge is generally similar after all these hypnotic
agents [14-16]. Sevoflurane-induced anaesthesia is gener-
ally well-received and causes fewer side effects than propo-
fol such as hypotension and apnea [9]. When sevoflurane
is used for maintenance, the postoperative nausea and
vomiting rate is comparable to that for other inhaled
anaesthetics, although this complication is more frequent
when used for induction. Sevoflurane’s tolerability and low
solubility make it easier to titrate anaesthesia and may
reduce the need for opioid analgesia, thus possibly
decreasing the incidence of nausea and vomiting side
effects [17-19].
Desflurane
Desflurane is a halogenated inhalational anaesthetic agent
administered by vaporization and used to maintain gen-
eral anaesthesia. The minimum alveolar concentration
(MAC) in oxygen mixture for a 40-year-old-adult is 6%
and decreases with age. Despite its high cost, together
with sevoflurane, it is gradually replacing isoflurane for
use in general anesthesia. It has the most rapid onset and
offset of the volatile anaesthetics due to its low solubility
in the blood [4,14]. The major drawbacks of desflurane
are its low potency and high pungency, and that it tends
to induce airway irritability and therefore, is not pre-
ferred as an induction volatile anaesthetic. On the other
hand, Desflurane presents with the advantage that
beyond a cut-off value of 5-6% of inspired concentration,
it induces an augmented sympathetic tone with increased
heart rate and arterial hypertension, instead of producing
a dose-dependent peripheral vasodilatation response
[19,20]. Because of the low blood-lipid coefficient that
results in limited storage in theadipose tissue and the
reduced risk of arterial hypotension, its use might be
associated with a lower rate of postoperative delirium
[4,18].
Fentanyl
To minimize confounding variables fentanyl will be used
as an opioid for pain management in all study groups.
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Fentanyl is an half-life opioid analgesic that interacts
predominately with the μ opioid-receptor and exerts its
principal pharmacologic effects on the central nervous
system. Its primary actions of therapeutic value are
analgesia and sedation with favorable side-effect profile.
Fentanyl may increase the patient’s tolerance for pain
[19,20].
Methods
The PINOCCHIO study is a multicentre, double-blind,
phase II, prospective, randomized, controlled clinical
trial, designed to evaluate postoperative delirium rate
after general anaesthesia with various hypnotics in
patients undergoing surgical procedures other than car-
diac or brain surgery. A secondary end point is to detect
whether delayed postoperative cognitive recovery is
related to an increased risk of PD.
Enrolment criteria will be assessed in all patients dur-
ing the routine preoperative assessment and physical
examination. After obtaining institutional board approval
(IRB), each centre will recruit and randomly assign (with
a computerized randomization procedure) patients to
one of three treatment arms to receive desflurane, sevo-
flurane or propofol for anaesthesia maintenance. Patients
will be randomly assigned to one of these three strategies
with equal probability. Balanced randomization will be
maintained at each clinical site using a blocked randomi-
zation scheme. Patients will be randomized the day
before surgery, once the patient has provided written
informed consent and satisfied all the study eligibility cri-
teria. The number of years that patients attended school
will be recorded.
Inclusion and exclusion criteria
Inclusion criteria are age > 18 and < 75 years; American
Society of Anesthesiology (ASA) I-III; with no neurolo-
gical deficits and Glasgow Coma Scale (GCS) Score of
15 [21,22].
Exclusion criteria: Patients with a history of drug
abuse, preoperatively foreseen delayed extubation; any
condition preventing proper evaluation of cognitive
functions such as speech and sensory impairment or
psychiatric disorders (language difficulties or psychiatric
organic dysfunctions) that could make difficult to
administer psychometric tests, will not be enrolled in
this study.
To minimize the influence of surgical procedures on
postoperative neurocognitive status, patients undergoing
cardiac or brain surgery will be excluded. To reduce the
risk of PD, premedication benzodiazepine or atropine
will be avoided, because the use of these drugs is asso-
ciated, especially in patients at higher risk, to an excess of
PD incidence [23,24]. Premedication could be accom-
plished with fentanyl (up to 1 mcg/kg) or propofol (up to
0.5 mg/kg). All patients will receive isotonic crystalloid
saline solution (5 mL/kg) before anaesthesia induction to
minimize the risk of arterial hypotension after anaesthe-
sia induction and will be preoxygenated for 3 minutes
with a reservoir bag in 100% O2 before intubation to pre-
vent hypoxia. After anaesthesia induction a second intra-
venous line will be placed for study drug administration
purposes. In all patients, anaesthesia will be induced with
propofol (2-3 mg/kg IV), fentanyl (2 to 4 μg/kg IV) and
non-depolarizing neuromuscular blocking drugs.
After tracheal intubation, patients will be mechanically
ventilated with an inspired mixture of air and oxygen
(1:1). Ventilation, using a semi-closed breathing system
with a fresh gas flow of at least 2 L/min during anaesthesia
maintenance, will be adjusted to achieve end-tidal carbon
dioxide varying from 30-35 mmHg. No local anaesthesia
will be allowed. Anaesthesia will be maintained according
to one of the following three study groups: desflurane +
fentanyl: desflurane will be maintained in a 5.6 to
6.1 MAC intervals and fentanyl (2-3 μg/kg/h or 0.7 μg/kg
boluses). If necessary, fentanyl (1-2 μg/kg/h) can be sup-
plemented just before skin incision; sevoflurane + fentanyl:
sevoflurane will be maintained in a 0.75 to 1.25 MAC
interval and fentanyl (2-3 μg/kg/h or 0.7 μg/kg boluses). If
necessary, fentanyl (1-2 μg/kg/h) can be supplemented
just before skin incision; propofol + fentanyl: propofol will
be maintained with continuous infusion at 10 mg/kg/h for
the first 10 minutes, then reduced to 8 mg/kg/h for the
ensuing 10 minutes and reduced to 6 mg/kg/h thereafter.
If necessary, fentanyl (1-2 μg/kg/h) can be supplemented
just before skin incision.
The administration of the assigned hypnotic (desflurane,
sevoflurane or propofol) will be stopped at skin dressing.
During awakening phase fresh gas flow will be increased
to the “minute volume” of the individual patient. When
surgery ends, residual neuromuscular blockade will be
antagonized with neostigmine 2.5 mg and atropine 1 mg
or glycopirrolate at 25% recovery of the first train of four
(TOF)-induced twitch and patients were allowed to
recover to a TOF ratio of 0.9. Administration of paraceta-
mol (1 g IV) for postoperative analgesia, will be started at
surgical wound closure and continued at the dose of 1 g 3
times/day, if necessary opioids can be used to supplement
postoperative analgesia.
Postoperative (post-anesthesia) pain will be evaluated
every 20 minutes, once patients reach a postoperative
Aldrete score ≥ 9, for the first postoperative hour (20,
40, and 60 min) [25]. Research assistants, unaware of
the group assignment, will record postoperative pain
scores reported by patients during structured interviews
using a verbal version of the Visual Analog Scale (VAS),
in which a rating of zero corresponds to no pain, ratings
of 1-4 indicate moderate pain, and ratings of 5-10 corre-
spond to severe pain [26].
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Postoperative (post-anesthesia) cognitive function will be
evaluated with 2 test batteries administered individually to
all patients at 4 times: before surgery (baseline), and post-
operatively-after patients reach a postoperative Aldrete
score ≥ 9-every 20 minutes for the first postoperative hour
(20, 40, and 60 min). The Short Orientation Memory Con-
centration Test (SOMCT) is a patient-based test designed
to assess cognitive function in terms of level of orientation,
memory, and concentration. The SOMCT requires sub-
jects to recall the current year, month, time, a complete
sentence, and to repeat in numerical and reverse order the
sequence of the months of the year. These 6 variables yield
scores varying from 0 to 28, with higher scores indicating
better cognitive function [27,28] (Appendix 1, Table 1).
The Rancho Los Amigos Scale is a physician-based scale
designed to quantify behavioural and cognitive status after
acute brain injuries also used in the postoperative intensive
care setting. Each state corresponds to 1 of 8 levels, varying
from I to VIII, with higher levels indicating better beha-
vioural and cognitive status (Appendix 2, Table 2). Both
scales will be evaluated preoperatively and postoperatively
by 2 experienced physicians unaware of the group assign-
ment. If the 2 observers’ score disagree, the opinion of a
third observer will be considered discriminant. The Aldrete
score will be assessed by a trained anaesthesiologist,
blinded to the allocation treatment group [26]. Every 30-60
seconds the anaesthesiologist will score the patients’ activ-
ity (ability to move extremities), respiration (ability to
cough and breath), circulation (differences in blood pres-
sure from patient’s personal baseline), consciousness (abil-
ity to keep awake) and skin color (level of peripheral
oxygen saturation).
The incidence of postoperative delirium will be evalu-
ated using the Nursing Delirium Scale (Nu-Desc) a tool
that can be easily integrated into routine care and clini-
cal practice. The Nu-Desc is a five-item scale that
comprises a fifth item for the rating of unusual psycho-
motor retardation. This scale also takes into account the
subjects medical condition (delayed responsiveness, few
or no spontaneous actions or words; for example, when
the patient is prodded, the reaction is deferred or the
patient is unarousable). A positive response to these
items brings the maximal screening score to 10. A score
of 2 or more on the Nu-Desc correctly identifies the
presence of delirium [29,30] (Appendix 3, Table 3). The
onset of postoperative delirium will be monitored with
Table 1 The Short Orientation Memory Concentration
Test












Count backwards from 20 to 1 Max score 4
Say the months of the year backwards Max score 4
Repeat the information given in the preceding
sentence
Max score 10
Table 2 The Rancho Los Amigos Scale (RLAS)
Level I No response to pain, touch, sound or sight
Level II Generalized reflex response to pain
Level III Localized response. Blinks to strong light, turns toward/
away from sound, responds to physical discomfort,
inconsistent response to commands
Level IV Confused/Agitated. Alert, performs motor activities but
behavior is non purposeful, extremely short attention span
Level V Confused/Non agitated. Gross attention to environment,
highly distractible, inappropriate verbalization
Level VI Confused/Appropriated. Inconsistent orientation to time
and place, consistently follows simple directions
Level VII Automatic/Appropriated. Skills noticeably deteriorated
Level VIII Purposeful/Appropriate
Table 3 The Nursing Delirium Screening Scale (Nu-DESC)
Symptoms Symptoms Rating






Verbal or behavioural manifestation of not
being oriented to time or place or
misperceiving persons in the environment.
2 Inappropriate behaviour
Behaviour inappropriate to place or for the
person; e.g., pulling at tubes or
dressings, attempting to get out of bed when
that is contraindicated, and the like.
3 Inappropriate communication
Communication inappropriate to place or for




Seeing or hearing things that are not there;
distortions of visual objects.
5 Psychomotor retardation
Delayed responsiveness, few or no spontaneous
actions/words; e.g., when the patient
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the Nu-DeSc every three hours up to 72 hours post
anaesthesia.
Statistical Analysis
Sample Size This trial has the objective to evaluate if
propofol + fentanyl, as well as sevoflurane + fentanyl, is
non inferior to desflurane + fentanyl, in terms of PD.
To test for non inferiority two comparisons are planned:
✓ propofol + fentanyl vs. desflurane + fentanyl
✓ sevoflurane + fentanyl vs. desflurane + fentanyl
A sample size of 275 patients for each study group,
with an allocation ratio of 1:1:1, for a total of 825
patients, is required to achieve 80% power -with a signif-
icance level of 0.05- to detect a non-inferiority margin
difference between the group percentage of 3% in the
primary end-point variable (PD rate). The reference
group percentage is 10%. The treatment group percen-
tage is assumed to be 13% under the null hypothesis of
inferiority. The power was computed for the case when
the actual treatment group percentage is 7%. Sample
size calculation has not been corrected for possible mul-
tiple comparisons. The statistical test used was the one-
sided Score test (Farrington & Manning) [31]. Calcula-
tions were implemented in PASS2005 [32].
Patients will be randomly assigned in consecutive
order in allocation blocks. No patient stratification will
be done. Dunnett’s test will be used after ANOVA to
test the null hypothesis that no group has its mean sig-
nificantly different from the mean of the reference
group [33].
Ethical considerations
The Pinocchio study will be conducted according to the
principles of the Declaration of Helsinki (version of
2004). The Medical Ethics Committee of the Policlinico
Umberto I approved the protocol before start of the trial
(May 18, 2007 N 426/07; President Prof Aldo Isidori).
Approval by the local medical ethical review board is
required for each participating centre before start of
inclusion. In advance of the trial starting at a site the
Principal Investigator must agree to adhere to Good
Clinical Practice Guidelines and all relevant regulations
in their country.
Results
The first patient was recruited in September 2010. Cur-
rently 2 centres have obtained local IRB approval. To
date (April 2011) 269 patients have been enrolled in the
study.
Discussion
The results of this multicentre, double-blind, prospec-
tive, randomized, controlled clinical trial will help
anaesthesiologists to be able to choose the hypnotic
drug least likely to induce PD after general anaesthesia
for surgical procedures other than cardiac or brain sur-
gery. By clarifying the influence of PD on early post-
operative cognitive impairment our findings should also
help tailor hypnotic-anaesthesiological strategies to the
individual patient. The subgroup analysis used to cate-
gorize patients according to demographic variables rele-
vant to the risk of PD (age, sex, body weight) and to the
preoperative score index for delirium, should help to
defined the risks of PD in the various subgroups.
We sought that excluding patients undergoing surgical
procedures other than cardiac or brain surgery will mini-
mize the influence of hemodynamic variablitiy and the
surgical procedure per se on the postoperative neurocog-
nitive status of the patients. The risk of PD can be pre-
dicted and effective strategies exist to reduce this risk. In
126 patients undergoing hip fracture repair to receive
usual care alone or supplemented by several additional
measures (including: supplemental oxygen during surgery,
optimizing electrolytes and blood glucose preoperatively,
discontinuing high-risk medications, maintaining adequate
nutritional intake, encouraging patients to get out of bed
on the first postoperative day, treating severe pain), reduce
delirium rate from 50% to 32% in the intervention group
and severe delirium rate from 29% to 12% [34].
Several drugs can increase the risk of PD and worsen
postoperative cognitive recovery. Perioperative atropine
and other drugs with anticholinergic properties, ie, benzo-
diazepines and the opioid agent meperidine increase the
risk of PD. In general, the older the patient, the less appro-
priate are these agents [24]. Many drugs not typically
recognized as anticholinergics, including tricyclic antide-
pressants, first-generation antihistamines and high-dose
H2-receptor blockers may have potent anticholinergic
activity therefore these agents too should be avoided in
elderly patients [35]. Postoperative impairment of memory
and concentration has been attributed to benzodiazepines
in elderly patients undergoing cataract surgery, with a sta-
tistically significant correlation between the extent of
impairment in the memory performance and amount of
nitrazepam given during the postoperative week [36].
Previous reports suggest as significant risk factors for
PD, increasing age, blood urea levels, cardiothoracic index,
hypertension, smoking habits, blood replacement during
bypass, atrial fibrillation (AF), pneumonia, and postopera-
tive blood fluid balance. These reports also include prior
cognitive impairment and reduced hemoglobin and hema-
tocrit levels [37,38]. Preoperative fluid fasting is an inde-
pendent risk factor for early PD and dehydration is a
known risk factor for delirium [39,40]. To minimize this
relationship, during anaesthesia induction, patients will
receive isotonic crystalloid saline solution (5 mL/kg)
through a peripheral intravenous catheter.
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For PD screening we used the Nu-Desc which assesses
five signs or symptoms: orientation, behaviour, commu-
nication, illusions and psycho-motor retardation
(Appendix 1, Table 1). Each sign or symptom is rated
on a three-point scale, from 0 (indicating the absence of
the described sign or symptom) to 2 (indicating that the
sign or symptom fulfils all the diagnostic criteria) [29].
According to this scale a cumulative score of ≥ 2 is
diagnostic for PD. The Nu-Desc has high diagnostic
specificity and excellent sensitivity and is the most
appropriate scale for the perioperative setting [30].
In conclusion, the results of this comparative anaes-
thesiological trial should allow us to detect whether the
use of each of the three hypnotics tested is related to a
significant difference in PD rate. This information could
ultimately help in selecting the most appropriate hypno-
tic to maintain anaesthesia in a specific subgroup of






PD: Postoperative Delirium; POCD: Postoperative Cognitive Dysfunction;
MAC: Minimum Alveolar Concentration; IBA: Institutional Board Approval;
ASA: American Society of Anesthesiology; GCS: Glasgow Coma Scale; Nu-
Desc: Nursing Delirium Scale; SOMCT: Short Orientation Memory
Concentration Test; RLAS: Rancho Los Amigos Scale; AF: Atrial Fibrillation.
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